Stellantis' turnaround plan, prediction market regulation, Oura's IPO filing and more in Morning Squawk

Microsoft is reportedly in talks to supply custom AI chips to Anthropic, a potential strategic win in the AI race following Microsoft's $5 billion investment last November. Stellantis unveiled a nearly $70 billion five-year plan targeting positive free cash flow next year and 35% sales growth in North America by 2030, while Oura confidentially filed to go public and is on pace to surpass five million paid members this quarter. The piece also highlights political friction over a $1.8 billion DHS funding package and rising regulatory scrutiny of prediction markets, including a House investigation into insider trading on Kalshi and Polymarket.

Analysis

The cleanest near-term read is that AI spend is becoming less about model quality and more about control points in the stack: chips, distribution, and enterprise workflows. Microsoft’s move would reduce its dependence on third-party accelerators at the exact moment hyperscalers are trying to lock in differentiated supply, which is incrementally negative for the “commodity GPU” narrative and positive for any non-Nvidia custom silicon ecosystem. That also creates a second-order winner set in foundry, advanced packaging, and networking, because custom chips tend to pull more design wins through the rest of the hardware chain than the market models at headline capex levels.

The more interesting signal is Workday: when a mature enterprise software name can lift margin guidance on AI demand, it implies AI monetization is finally reaching budget lines, not just pilot projects. That shifts the trade from pure semis-beta into application-layer names with pricing power and lower customer-acquisition friction. By contrast, Microsoft’s deeper AI entrenchment is mildly negative for Amazon and Google because it raises the bar for cloud differentiation and could pressure share in enterprise AI workloads over the next 6-12 months.

Stellantis is a different setup: the scale of investment reads bullish on paper, but the real variable is execution quality, not spending. Positive free cash flow by next year is a high bar for a company simultaneously trying to refresh product, defend North America, and reset its mix; if inventory discipline slips, the market will punish the stock quickly. The antimony loan to Perpetua is more important than the equity headline: it reinforces a domestic critical-minerals bid, which is a structural tailwind for developers with U.S. permitting optionality and a strategic negative for import-dependent supply chains.

Key Decisions for Investors

• Long MSFT / short AMZN or GOOGL for 3-6 months: if Microsoft secures custom AI silicon with Anthropic, it strengthens Azure’s enterprise moat while the competitive pressure on cloud AI differentiation remains asymmetric.
• Add to WDAY on pullbacks for a 1-3 month trade: margin expansion tied to AI demand suggests the market may still be underpricing enterprise software monetization; use a tight stop if the post-earnings move fades below the gap level.
• Pair long AVGO vs short NVDA into the next 4-8 weeks: custom-chip design wins and AI infrastructure expansion should benefit diversified silicon exposure more than a pure GPU multiple if capex expectations keep broadening.
• Tactically long STLA only as a catalyst trade, not a core hold: best risk/reward is around execution milestones over the next 2 quarters; fade rallies if free-cash-flow credibility is not confirmed by inventory and margin data.
• Long PPTA on a 6-12 month horizon as a strategic materials optionality trade: the loan de-risks project financing, but size modestly because permitting and timing remain the main breakpoints.